We are live on
!
Find out more
HA
Hamel Associates Portfolio holdings
AUM
$363M
1-Year Est. Return
24.39%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+24.39%
3 Year Est. Return
+50.64%
5 Year Est. Return
+68.03%
10 Year Est. Return
+174.56%
AUM
$363M
AUM Growth
+$12.1M
(+3.5%)
Cap. Flow
+$9.58M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
41.34%
Holding
94
New
13
Increased
21
Reduced
43
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$11.7M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$3.19M |
| 3 |
Huntington Ingalls Industries
HII
|
+$1.79M |
| 4 |
Abbott
ABT
|
+$1.59M |
| 5 |
Kroger
KR
|
+$321K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$2.94M |
| 2 |
Verizon
VZ
|
+$1.44M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.11M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$957K |
| 5 |
Apple
AAPL
|
+$879K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.16% |
| 2 | Consumer Staples | 11.69% |
| 3 | Financials | 10.3% |
| 4 | Technology | 9.31% |
| 5 | Industrials | 9.13% |
Similar funds
VIA
RC
MS
WI
HS
MA
SIAG
BHBT
Hamel Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Hamel Associates held 94 positions worth $363M, up 3.5% from $351M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Hamel Associates's Q2 2026 filing shows 13 new, 21 increased, 43 reduced and 2 closed positions. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 232,135 shares worth $11.7M. The largest sale was Honeywell, an estimated $2.94M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Financials.
- Hamel Associates's largest Q2 2026 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 232,135 shares worth $11.7M.
- Hamel Associates added most to Huntington Ingalls Industries in Q2 2026, an estimated $1.79M increase.
- Hamel Associates's biggest Q2 2026 reduction was Honeywell, cutting an estimated $2.94M.
- Hamel Associates fully exited Bristol-Myers Squibb in Q2 2026, selling an estimated $220K.
- Hamel Associates's ten largest holdings make up 41% of its $363M portfolio in Q2 2026.
- Hamel Associates opened 13 new positions and closed 2 in Q2 2026.
- Hamel Associates's portfolio value rose 3.5% quarter-over-quarter to $363M.
Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.